OncoTherapy Science's total assets for Q3 2024 were ¥1.23B, a decrease of -20.42% from the previous quarter. DE:30O total liabilities were ¥404.00M for the fiscal quarter, a -26.24% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.